Paper20145124
NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer.
Sikandar SS and 6 others. Cancer Res, 2010. Cited by 239 papers, by iCite.
Cite this record
ConductScience Library. NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer. Papers, record 20145124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20145124
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma | Major topic |
| Cell Differentiation | Major topic |
| Cell Proliferation | Major topic |
| Cell Transformation, Neoplastic | Major topic |
| Colonic Neoplasms | Major topic |
| Enteroendocrine Cells | Major topic |
| Neoplastic Stem Cells | Major topic |
| Receptor, Notch1 | Major topic |
| Animals | |
| Biomarkers, Tumor | |
| HCT116 Cells | |
| HT29 Cells | |
| Humans | |
| Mice | |
| Mice, Inbred NOD | |
| Mice, SCID | |
| RNA, Small Interfering | |
| Signal Transduction | |
| Tumor Cells, Cultured | |
| Xenograft Model Antitumor Assays |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| HHSN261201200018I | NCI NIH HHS | United States | PubMed | PubMed | |
| R21 CA162483 | NCI NIH HHS | United States | R21CA162483 | PubMed and NIH | NIH RePORTER |
| R01 CA108697 | NCI NIH HHS | United States | R01CA108697 | PubMed and NIH | NIH RePORTER |
| CA108697 | NCI NIH HHS | United States | R01CA108697 | PubMed and NIH | NIH RePORTER |
| R56 CA098626 | NCI NIH HHS | United States | R56CA098626 | PubMed and NIH | NIH RePORTER |
| P30 CA062203 | NCI NIH HHS | United States | P30CA062203 | PubMed and NIH | NIH RePORTER |
| R21 CA153049 | NCI NIH HHS | United States | R21CA153049 | PubMed and NIH | NIH RePORTER |
| CA09878 | NCI NIH HHS | United States | PubMed | PubMed |
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8861899 | Lessons from hereditary colorectal cancer. | Cell | 1996 | https://conductscience.org/library/papers/8861899 | PubMed |
| 2 | 17548814 | Phenotypic characterization of human colorectal cancer stem cells. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17548814 | PubMed |
| 3 | 18320325 | The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway. | Dig Dis Sci | 2008 | https://conductscience.org/library/papers/18320325 | PubMed |
| 4 | 17122771 | Identification and expansion of human colon-cancer-initiating cells. | Nature | 2007 | https://conductscience.org/library/papers/17122771 | PubMed |
| 5 | 18166351 | Gamma-secretase inhibitors enhance taxane-induced mitotic arrest and apoptosis in colon cancer cells. | Gastroenterology | 2008 | https://conductscience.org/library/papers/18166351 | PubMed |
| 6 | 19020755 | Activation of Notch signaling in human colon adenocarcinoma. | Int J Oncol | 2008 | https://conductscience.org/library/papers/19020755 | PubMed |
| 7 | 9697701 | Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. | Nat Genet | 1998 | https://conductscience.org/library/papers/9697701 | PubMed |
| 8 | 15716339 | Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine. | Development | 2005 | https://conductscience.org/library/papers/15716339 | PubMed |
| 9 | 8385741 | Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. | N Engl J Med | 1993 | https://conductscience.org/library/papers/8385741 | PubMed |
| 10 | 18942891 | Proteomic profiling of gamma-secretase substrates and mapping of substrate requirements. | PLoS Biol | 2008 | https://conductscience.org/library/papers/18942891 | PubMed |
| 11 | 19308264 | MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. | PLoS One | 2009 | https://conductscience.org/library/papers/19308264 | PubMed |
| 12 | 12637581 | Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12637581 | PubMed |
| 13 | 18621050 | Intestinal deletion of Pofut1 in the mouse inactivates notch signaling and causes enterocolitis. | Gastroenterology | 2008 | https://conductscience.org/library/papers/18621050 | PubMed |
| 14 | 16885340 | Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. | Cancer Res | 2006 | https://conductscience.org/library/papers/16885340 | PubMed |
| 15 | 8565827 | Genes of the Enhancer of split and achaete-scute complexes are required for a regulatory loop between Notch and Delta during lateral signalling in Drosophila. | Development | 1996 | https://conductscience.org/library/papers/8565827 | PubMed |
| 16 | 18356041 | Recent advances in cancer stem cells. | Curr Opin Genet Dev | 2008 | https://conductscience.org/library/papers/18356041 | PubMed |
| 17 | 10206645 | A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. | Nature | 1999 | https://conductscience.org/library/papers/10206645 | PubMed |
| 18 | 11076877 | Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. | Gut | 2000 | https://conductscience.org/library/papers/11076877 | PubMed |
| 19 | 8298943 | Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. | Br J Surg | 1993 | https://conductscience.org/library/papers/8298943 | PubMed |
| 20 | 18442654 | Isolation and culture of colon cancer stem cells. | Methods Cell Biol | 2008 | https://conductscience.org/library/papers/18442654 | PubMed |
Cited by161
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 239 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42882474 | Acquired Chemoresistance in Colorectal Cancer: Therapy-Induced Signalling Adaptation, Cellular Plasticity and Mechanism-Guided Therapeutic Strategies. | Cells | 2026 | https://conductscience.org/library/papers/42882474 | PubMed |
| 42649883 | Cancer Stem Cells in Colorectal Cancer: From Molecular Mechanisms to Diagnosis, Prognosis and Therapy Implications. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42649883 | PubMed |
| 42426902 | Cancer stem cell plasticity: mechanisms, immune microenvironment crosstalk, and therapeutic implications. | J Hematol Oncol | 2026 | https://conductscience.org/library/papers/42426902 | PubMed |
| 41997917 | Dedifferentiation-driven oncogenic stemness promotes tumor-sustaining adaptability in the intestinal epithelium. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41997917 | PubMed |
| 41501898 | Increased prolactin levels in pregnancy affect colorectal cancer aggressiveness. | BMC Biol | 2026 | https://conductscience.org/library/papers/41501898 | PubMed |
| 41423446 | YTHDF1 targets the chemotherapy response by suppressing NOTCH1-induced stemness in colorectal cancer. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/41423446 | PubMed |
| 41294868 | The Two-Way Role of Jagged1 in Cancer: A Focus on CRC. | Cells | 2025 | https://conductscience.org/library/papers/41294868 | PubMed |
| 41062962 | A Notch signal pathway related gene signature predicts overall survival in colorectal cancer. | BMC Gastroenterol | 2025 | https://conductscience.org/library/papers/41062962 | PubMed |
| 40531261 | E2F2/MUC1 Enhances Cell Stemness of Hepatocellular Carcinoma by Regulating the Notch Signaling Pathway. | Dig Dis Sci | 2025 | https://conductscience.org/library/papers/40531261 | PubMed |
| 40052152 | Notch signaling in cancers: mechanism and potential therapy. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40052152 | PubMed |
| 39859345 | Molecular Mechanisms of Dietary Compounds in Cancer Stem Cells from Solid Tumors: Insights into Colorectal, Breast, and Prostate Cancer. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39859345 | PubMed |
| 39035582 | Evaluation of in vitro and in vivo anticancer activities of potassium koetjapate: a solubility improved formulation of koetjapic acid against human colon cancer. | Res Pharm Sci | 2024 | https://conductscience.org/library/papers/39035582 | PubMed |
| 38441855 | The SOX2/PDIA6 axis mediates aerobic glycolysis to promote stemness in non-small cell lung cancer cells. | J Bioenerg Biomembr | 2024 | https://conductscience.org/library/papers/38441855 | PubMed |
| 38254219 | Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs. | Exp Hematol Oncol | 2024 | https://conductscience.org/library/papers/38254219 | PubMed |
| 37986165 | Machine learning-based analysis of cancer cell-derived vesicular proteins revealed significant tumor-specificity and predictive potential of extracellular vesicles for cell invasion and proliferation - A meta-analysis. | Cell Commun Signal | 2023 | https://conductscience.org/library/papers/37986165 | PubMed |
| 37860822 | Notch receptor/ligand diversity: contribution to colorectal cancer stem cell heterogeneity. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37860822 | PubMed |
| 37824217 | Loss of ATOH1 in Pit Cell Drives Stemness and Progression of Gastric Adenocarcinoma by Activating AKT/mTOR Signaling through GAS1. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/37824217 | PubMed |
| 37338390 | Targeting intratumor heterogeneity suppresses colorectal cancer chemoresistance and metastasis. | EMBO Rep | 2023 | https://conductscience.org/library/papers/37338390 | PubMed |
| 37274780 | Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma. | Front Genet | 2023 | https://conductscience.org/library/papers/37274780 | PubMed |
| 37200816 | The Intricate Notch Signaling Dynamics in Therapeutic Realms of Cancer. | ACS Pharmacol Transl Sci | 2023 | https://conductscience.org/library/papers/37200816 | PubMed |
Genes28
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20145124
GET https://conductscience.org/api/papers/v1/20145124/references?page=2